(Q42646950)

4 November 2017

title

Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers (English)

1 reference

4 November 2017

0 references

Zhi J

1

1 reference

4 November 2017

Melia AT

2

1 reference

4 November 2017

Funk C

3

1 reference

4 November 2017

Viger-Chougnet A

4

1 reference

4 November 2017

Hopfgartner G

5

1 reference

4 November 2017

Lausecker B

6

1 reference

4 November 2017

Wang K

7

1 reference

4 November 2017

Fulton JS

8

1 reference

4 November 2017

Gabriel L

9

1 reference

4 November 2017

Mulligan TE

10

1 reference

4 November 2017

publication date

1 November 1996

1 reference

The Journal of Clinical Pharmacology

4 November 2017

published in

1 reference

4 November 2017

volume

36

1 reference

4 November 2017

issue

11

1 reference

4 November 2017

page(s)

1006-1011

1 reference

Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F009127009603601104

Crossref

reference URL

Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009603601104

Crossref

reference URL

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F009127009603601104

Crossref

reference URL

10.1177/009127009603601104

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference